Li Kang Biomedical Co., Ltd. (TPEX:6242)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
38.15
+0.15 (0.39%)
Jun 12, 2026, 1:30 PM CST
Market Cap1.21B -7.1%
Revenue (ttm)575.98M -0.2%
Net Income77.56M -4.7%
EPS2.44 -4.5%
Shares Out 31.81M
PE Ratio15.66
Forward PEn/a
Dividend2.00 (5.24%)
Ex-Dividend DateJun 16, 2026
Volume14,232
Open38.00
Previous Close38.00
Day's Range38.00 - 38.80
52-Week Range36.60 - 43.70
Beta-0.06
Analystsn/a
Price Targetn/a
Earnings DateAug 7, 2026

About Li Kang Biomedical

Li Kang Biomedical Co., Ltd. produces and sells pharmaceuticals, beauty products, and health food. It offers Chinese and Western medicines, nutritional supplements, beauty and skincare products, and daily necessities products. The company was formerly known as BAFO Technologies Corporation and changed its name to Li Kang Biomedical Co., Ltd. in September 2014. Li Kang Biomedical Co., Ltd. was founded in 1982 and is based in Tainan City, Taiwan. [Read more]

Founded 1982
Employees 122
Stock Exchange Taipei Exchange
Ticker Symbol 6242
Full Company Profile

Financial Performance

In 2025, Li Kang Biomedical's revenue was 589.21 million, an increase of 4.19% compared to the previous year's 565.52 million. Earnings were 83.82 million, an increase of 8.83%.

Financial Statements